7/10/2020 | BKCVDDEMHY | Prospect News reports nine new defaults for week of July 2 to July 8
|
7/6/2020 | BKCVDDHY | Endologix files pre-packaged bankruptcy; Deerfield Partners to swap debt for equity
|
2/24/2020 | CVLMPV | Endologix to swap some 2020 convertibles, amend debt facilities
|
1/16/2020 | BKBWCVHY | Endologix reports completion of a ‘major debt refinancing’ in 2019
|
4/1/2019 | CVLM | Endologix holders exchange $73.36 million 3.25% convertible notes
|
10/24/2018 | CVLM | Endologix to redeem 2.25% convertible notes via stock sale proceeds
|
4/4/2017 | CVLM | Endologix to repurchase $53.1 million 2.25% convertibles due 2018
|
11/16/2016 | CV | Market Commentary: Weatherford, AMD gain; Endologix drops sharply; Medicines up; PDL BioPharma deal on tap
|
12/31/2015 | CV | Market Commentary: Outlook 2016: Convertibles primary market seen in line to higher after disappointing 2015
|
10/29/2015 | CV | Endologix greenshoe exercise increases convertibles to $125 million
|
10/28/2015 | CV | Market Commentary: Downsized Endologix trades up on debut; Kinder Morgan trades better; Integrated Device Technology on tap
|
10/28/2015 | CV | Market Commentary: Morning Commentary: Downsized Endologix trades up on debut; Kinder Morgan better; Twitter shares sink
|
10/28/2015 | CV | New Issue: Endologix prices downsized $110 million five-year convertible notes to yield 3.25%, up 27.5%
|
10/27/2015 | CV | Market Commentary: Kinder Morgan mandatory trades lower on debut, Endologix shares plunge ahead of pricing
|
10/27/2015 | CV | Market Commentary: Morning Commentary: New Kinder Morgan mandatory trades lower, Endologix shares plunge
|
10/26/2015 | CV | Market Commentary: Kinder Morgan plans $1.6 billion mandatory; Endologix on tap for $150 million; Ctrip jumps in active trade
|
10/26/2015 | CV | Endologix to price $150 million three-year convertibles to yield 2.75%-3.25%, up 27.5%-32.5%
|
3/3/2014 | CV | Market Commentary: Tesla lags from issue; Yandex slumps on Russia-Ukraine conflict; Akorn down after earnings
|
12/31/2013 | CV | Outlook 2014: U.S. secondary market poised for continued strength, but investors eye Fed taper
|
12/9/2013 | CV | Endologix greenshoe lifts 2.25% convertibles to $86.25 million
|
12/6/2013 | CV | Market Commentary: Midday Commentary: New Proofpoint, HCI add on hedge; GT Advanced, Endologix, SouFun shares lower
|
12/6/2013 | CV | Market Commentary: Proofpoint adds on hedge as shares fade; HCI Group adds on debut; secondary market quiet
|
12/5/2013 | CV | New Issue: Endologix prices $75 million five-year convertible notes to yield 2.25%, up 32.5%
|
12/5/2013 | CV | Market Commentary: GT Advanced, Endologix gain on hedge; SouFun, American Realty mostly in line; RAIT drops
|
12/4/2013 | CV | Market Commentary: RPM gains outright on debut; planned GT Advanced deal talk tightened; existing GT in line
|
12/4/2013 | CV | Market Commentary: Midday Commentary: New RPM International adds early on debut; RAIT Financial launches deal
|
12/3/2013 | CV | Endologix plans $75 million five-year convertibles to yield 2.25%-2.75%, up 27.5%-32.5%
|
12/3/2013 | CV | Market Commentary: New Orexigen trends toward par; planned RPM deal in focus; GT Advanced, Endologix on tap
|
5/30/2012 | CVHYPF | Endologix files automatic shelf covering debt, stock and preferreds
|
5/8/2009 | CV | Endologix files $50 million shelf registration covering stock, debt
|